These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22348878)

  • 21. The mitochondrial p53 pathway.
    Vaseva AV; Moll UM
    Biochim Biophys Acta; 2009 May; 1787(5):414-20. PubMed ID: 19007744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer: Mutant p53 and chromatin regulation.
    Prives C; Lowe SW
    Nature; 2015 Sep; 525(7568):199-200. PubMed ID: 26331537
    [No Abstract]   [Full Text] [Related]  

  • 23. Transcriptional activities of mutant p53: when mutations are more than a loss.
    Kim E; Deppert W
    J Cell Biochem; 2004 Nov; 93(5):878-86. PubMed ID: 15449312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of p53-dependent transcription and enhancer activity by the p53 family member p63.
    Karsli Uzunbas G; Ahmed F; Sammons MA
    J Biol Chem; 2019 Jul; 294(27):10720-10736. PubMed ID: 31113863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs, wild-type and mutant p53: more questions than answers.
    Jones M; Lal A
    RNA Biol; 2012 Jun; 9(6):781-91. PubMed ID: 22664917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.
    Riscal R; Schrepfer E; Arena G; Cissé MY; Bellvert F; Heuillet M; Rambow F; Bonneil E; Sabourdy F; Vincent C; Ait-Arsa I; Levade T; Thibaut P; Marine JC; Portais JC; Sarry JE; Le Cam L; Linares LK
    Mol Cell; 2016 Jun; 62(6):890-902. PubMed ID: 27264869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant p53 regulates enhancer-associated H3K4 monomethylation through interactions with the methyltransferase MLL4.
    Rahnamoun H; Hong J; Sun Z; Lee J; Lu H; Lauberth SM
    J Biol Chem; 2018 Aug; 293(34):13234-13246. PubMed ID: 29954944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of chicken p53 transcriptional function via parallel genome-wide chromatin occupancy and gene expression analysis.
    Chen Z; Cui L; Xu L; Liu Z; Liang Y; Li X; Zhang Y; Li Y; Liu S; Li H
    Poult Sci; 2022 Nov; 101(11):102164. PubMed ID: 36167023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcription regulation by mutant p53.
    Weisz L; Oren M; Rotter V
    Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear lncRNAs as epigenetic regulators-beyond skepticism.
    Nakagawa S; Kageyama Y
    Biochim Biophys Acta; 2014 Mar; 1839(3):215-22. PubMed ID: 24200874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 sumoylation: mechanistic insights from reconstitution studies.
    Wu SY; Chiang CM
    Epigenetics; 2009 Oct; 4(7):445-51. PubMed ID: 19838051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of p53 protein in human tumors.
    Inoue K; Kurabayashi A; Shuin T; Ohtsuki Y; Furihata M
    Med Mol Morphol; 2012 Jun; 45(3):115-23. PubMed ID: 23001293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Putting p53 in Context.
    Kastenhuber ER; Lowe SW
    Cell; 2017 Sep; 170(6):1062-1078. PubMed ID: 28886379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chromatin backdrop of DNA replication: lessons from genetics and genome-scale analyses.
    Conner AL; Aladjem MI
    Biochim Biophys Acta; 2012 Jul; 1819(7):794-801. PubMed ID: 22342530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidney.
    Li Y; Liu J; McLaughlin N; Bachvarov D; Saifudeen Z; El-Dahr SS
    Physiol Genomics; 2013 Oct; 45(20):948-64. PubMed ID: 24003036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor suppressive functions of p53.
    Zilfou JT; Lowe SW
    Cold Spring Harb Perspect Biol; 2009 Nov; 1(5):a001883. PubMed ID: 20066118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional regulation by p53.
    Beckerman R; Prives C
    Cold Spring Harb Perspect Biol; 2010 Aug; 2(8):a000935. PubMed ID: 20679336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo.
    Tsai WW; Nguyen TT; Shi Y; Barton MC
    Mol Cell Biol; 2008 Sep; 28(17):5139-46. PubMed ID: 18573881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromatin-modifying proteins in cancer.
    Fog CK; Jensen KT; Lund AH
    APMIS; 2007 Oct; 115(10):1060-89. PubMed ID: 18042144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
    Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
    Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.